Panbela Therapeutics (PBLA) Short Interest Ratio & Short Volume $0.16 0.00 (0.00%) As of 11:57 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsFDA EventsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Panbela Therapeutics Short Interest DataPanbela Therapeutics (PBLA) has a short interest of 100 shares, representing 0.00% of the float (the number of shares available for trading by the public). This marks a -50.00% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 16,156 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest200 sharesChange Vs. Previous Month-50.00%Dollar Volume Sold Short$17.00Short Interest Ratio0.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares4,855,000 sharesShort Percent of Float0.00%Today's Trading Volume5,559 sharesAverage Trading Volume16,156 sharesToday's Volume Vs. Average34% Short Selling Panbela Therapeutics? Sign up to receive the latest short interest report for Panbela Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPBLA Short Interest Over TimePBLA Days to Cover Over TimePBLA Percentage of Float Shorted Over Time Panbela Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025100 shares $17.00 -50.0%0.0%0 $0.17 7/15/2025200 shares $47.88 +100.0%N/A0 $0.24 6/30/2025100 shares $23.19 -50.0%0.0%0 $0.23 6/15/2025200 shares $60.00 No Change0.0%0 $0.30 5/31/2025200 shares $51.60 +100.0%0.0%0 $0.26 5/15/2025100 shares $30.00 -93.8%N/A0 $0.30 4/30/20251,600 shares $424.00 No ChangeN/A0.1 $0.27 4/15/2025100 shares $31.30 -66.7%N/A0 $0.31 3/14/2025300 shares $111.30 -95.5%N/A0 $0.37 2/14/2025300 shares $102.00 -25.0%N/A0 $0.34 Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2025400 shares $140.00 -94.0%N/A0 $0.35 1/15/20256,700 shares $2.81 thousand +6,600.0%N/A0.1 $0.42 2/29/2024114,700 shares $135.35 thousand +7.2%2.4%0.1 $1.18 2/15/2024107,000 shares $135.89 thousand -39.8%2.2%0.1 $1.27 1/31/2024177,700 shares $247.00 thousand +283.0%3.7%0.3 $1.39 1/15/202446,400 shares $584.64 thousand -96.6%9.7%0.2 $12.60 12/31/20231,350,000 shares $1.24 million +1,319.6%14.1%0.3 $0.92 12/15/202395,100 shares $43.47 thousand +115.7%1.9%0 $0.46 11/30/202344,100 shares $23.37 thousand -32.1%0.9%0 $0.53 11/15/202364,900 shares $39.13 thousand -22.2%1.3%0.1 $0.60 10/31/202383,400 shares $66.90 thousand +22.5%2.8%0.1 $0.80 10/15/202368,100 shares $70.14 thousand -21.5%2.3%0.6 $1.03 9/30/202386,700 shares $113.58 thousand -18.2%3.0%0.1 $1.31 9/15/2023106,000 shares $139.92 thousand +26.6%3.6%0.1 $1.32 8/31/202383,700 shares $116.34 thousand +335.9%2.9%0.1 $1.39 8/15/202319,200 shares $28.80 thousand -60.5%0.7%0 $1.50 7/31/202348,600 shares $97.69 thousand +102.5%1.7%0.1 $2.01 7/15/202324,000 shares $49.92 thousand -74.6%0.9%0 $2.08 6/30/202394,600 shares $217.58 thousand -50.3%3.4%0.4 $2.30 6/15/2023190,500 shares $1.11 million +590.2%6.9%0.9 $5.81 5/31/202327,600 shares $186.38 thousand -96.3%5.1%0.2 $6.75 5/15/2023754,400 shares $309.30 thousand -59.9%N/A0.3 $0.41 4/30/20231,880,000 shares $1.03 million -23.0%N/A0.6 $0.55 4/15/20232,440,000 shares $1.39 million +611.6%N/A0.9 $0.57 3/31/2023342,900 shares $151.63 thousand +3.9%N/A0.1 $0.44 3/15/2023330,200 shares $219.55 thousand -61.6%N/A0.2 $0.66 2/28/2023859,300 shares $1.18 million -18.2%13.7%0.5 $1.37 2/15/20231,050,000 shares $1.52 million +596.8%16.7%0.7 $1.45 1/31/2023150,700 shares $247.15 thousand -63.9%2.5%0.1 $1.64 1/15/2023417,700 shares $1.39 million -67.4%55.4%1.2 $3.32Cover all your expenses with just $118,000 invested? (Ad)Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just discovered a new way to do it with 10X less money.Start collecting this income (next payout coming soon) 12/30/20221,280,000 shares $93.82 thousand +60.5%N/A0.2 $0.07 12/15/2022797,500 shares $77.36 thousand +227.1%N/A0.2 $0.10 11/30/2022243,800 shares $33.01 thousand +354.9%N/A0.2 $0.14 11/15/202253,600 shares $8.52 thousand +51.8%N/A0.1 $0.16 10/31/202235,300 shares $4.47 thousand -23.9%N/A0 $0.13 10/15/202246,400 shares $10.35 thousand -95.6%N/A0.1 $0.22 9/30/20221,050,000 shares $283.82 thousand +276.9%N/A1.7 $0.27 9/15/2022278,600 shares $105.59 thousand +101.0%N/A0.5 $0.38 8/31/2022138,600 shares $95.74 thousand +9.4%N/A2.4 $0.69 8/15/2022126,700 shares $150.77 thousand -24.0%N/A2.7 $1.19 7/31/2022166,700 shares $206.71 thousand -4.9%N/A3.7 $1.24 7/15/2022175,300 shares $194.58 thousand +19.7%N/A3.9 $1.11 6/30/2022146,400 shares $96.64 thousand -4.6%N/A3.1 $0.66 6/15/2022153,500 shares $193.41 thousand +1.2%N/A4.4 $1.26 5/31/2022151,700 shares $227.55 thousand +31.0%N/A8.6 $1.50 5/15/2022115,800 shares $185.53 thousand -18.6%N/A4.1 $1.60 4/30/2022142,200 shares $251.69 thousand -14.3%N/A4.3 $1.77 4/15/2022165,900 shares $328.48 thousand +3.3%N/A4.5 $1.98 3/31/2022160,600 shares $338.87 thousand +9.9%N/A4.3 $2.11 3/15/2022146,200 shares $248.54 thousand -15.3%N/A3.2 $1.70 2/28/2022172,600 shares $336.57 thousand +21.8%N/A3.3 $1.95 2/15/2022141,700 shares $317.41 thousand -18.1%N/A2.4 $2.24 1/31/2022173,100 shares $368.70 thousand -6.2%N/A3.1 $2.13 1/15/2022184,600 shares $304.59 thousand -17.7%N/A3.3 $1.65 12/31/2021224,200 shares $387.89 thousand +18.9%N/A4.1 $1.73 12/15/2021188,600 shares $330.05 thousand -10.6%N/A3.7 $1.75 11/30/2021211,000 shares $390.35 thousand +5.3%N/A4.1 $1.85 11/15/2021200,300 shares $426.64 thousand -0.7%N/A3.5 $2.13 10/29/2021201,800 shares $431.85 thousand -1.5%N/A3.6 $2.14 10/15/2021204,900 shares $405.70 thousand +5.2%N/A1.6 $1.98 9/30/2021194,800 shares $422.72 thousand -9.4%N/A1.3 $2.17 9/15/2021214,900 shares $472.78 thousand -2.5%N/A0.9 $2.20 8/31/2021220,500 shares $500.54 thousand -14.7%N/A0.9 $2.27 8/13/2021258,400 shares $607.24 thousand +5.7%N/A1.1 $2.35 7/30/2021244,400 shares $615.89 thousand +12.5%N/A1 $2.52 7/15/2021217,200 shares $562.55 thousand -35.5%N/A1.3 $2.59 6/30/2021336,500 shares $952.30 thousand +85.2%N/A2.1 $2.83 6/15/2021181,700 shares $675.92 thousand -6.2%2.2%2.7 $3.72 5/28/2021193,800 shares $813.96 thousand +6.9%2.3%3 $4.20 5/14/2021181,300 shares $692.57 thousand -14.0%2.2%3.2 $3.82 4/30/2021210,900 shares $982.79 thousand +18.2%2.5%1.8 $4.66 4/15/2021178,400 shares $713.60 thousand -5.2%2.1%1.1 $4.00 3/31/2021188,100 shares $769.33 thousand -3.9%2.3%1.2 $4.09 3/15/2021195,700 shares $884.56 thousand +16.6%2.4%1.2 $4.52 2/26/2021167,800 shares $740.00 thousand -12.2%2.2%0.8 $4.41 2/12/2021191,000 shares $1.03 million +38.3%2.5%1 $5.38 1/29/2021138,100 shares $760.24 thousand +78.9%1.8%0.9 $5.51 1/15/202177,200 shares $633.04 thousand No Change1.0%0.8 $8.20 PBLA Short Interest - Frequently Asked Questions What is Panbela Therapeutics' current short interest? Short interest is the volume of Panbela Therapeutics shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 100 shares of PBLA short. 0.00% of Panbela Therapeutics' shares are currently sold short. Learn More on Panbela Therapeutics' current short interest. What is a good short interest percentage for Panbela Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of Panbela Therapeutics' floating shares are currently sold short. Is Panbela Therapeutics' short interest increasing or decreasing? Panbela Therapeutics saw a decline in short interest in the month of July. As of July 31st, there was short interest totaling 100 shares, a decline of 50.0% from the previous total of 200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Panbela Therapeutics' short interest compare to its competitors? 0.00% of Panbela Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Panbela Therapeutics: Enveric Biosciences, Inc. (11.92%), PMGC Holdings Inc. (7.84%), PainReform Ltd. (7.21%), Lipella Pharmaceuticals Inc. (0.10%), Galmed Pharmaceuticals Ltd. (2.11%), SciSparc Ltd. (2.53%), Aditxt, Inc. (5.07%), Can-Fite BioPharma Ltd. (10.13%), Universe Pharmaceuticals INC (10.17%), AIM ImmunoTech Inc. (117.02%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Panbela Therapeutics stock? Short selling PBLA is an investing strategy that aims to generate trading profit from Panbela Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Panbela Therapeutics? A short squeeze for Panbela Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PBLA, which in turn drives the price of the stock up even further. How often is Panbela Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBLA, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Enveric Biosciences Short Interest Data PMGC Short Interest Data PainReform Short Interest Data Lipella Pharmaceuticals Short Interest Data Galmed Pharmaceuticals Short Interest Data SciSparc Short Interest Data Aditxt Short Interest Data Can-Fite BioPharma Short Interest Data Universe Pharmaceuticals Short Interest Data AIM ImmunoTech Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PBLA) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access